drugset / Trial / NCT07387679
Myo-inositol Versus Metformin in Patients With Polycystic Ovarian Syndrome to Treat Obesity
RandomizedParallel-groupOpen-labelTreatment
Summary
There are considerable gaps in the comparative effectiveness and tolerability of myo-inositol and metformin for treating obesity in patients with polycystic ovarian syndrome (PCOS). The current study aimed to give insights comparing myo-inositol versus metformin for treating obesity in patients with PCOS.
Timeline
- Start
- 2024-11-29
- Primary completion
- 2025-05-28
- Completion
- 2025-05-28
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Inositol | Small molecule | 1 g | Oral |
| Subject | Metformin | Small molecule | 250 mg | — |